Overexpression of ribonuclease inhibitor defines good prognosis and suppresses proliferation and metastasis in human colorectal cancer cells via PI3K/AKT pathway

Clinical and Translational Oncology

Volumn 17, Issue 4, 2015, Pages 306-313

  Tang, Y ^a   Liu, P ^a   Tian, Y ^a   Xu, Y ^a   Ren, F ^a   Cui, X ^a   Fan, J ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Metastasis; PI3K Akt signal pathway; Ribonuclease inhibitor

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; RIBONUCLEASE INHIBITOR; VASCULOTROPIN; MESSENGER RNA; ONCOPROTEIN; PLACENTAL PEPTIDE HORMONE; PLACENTAL RIBONUCLEASE INHIBITOR;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HT 29 CELL LINE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; AGED; CLINICAL TRIAL; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; VERY ELDERLY; WESTERN BLOTTING; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; PLACENTAL HORMONES; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84925460978     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-014-1228-0     Document Type: Article

References (30)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. doi:10.3322/caac.21166.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.20107.
3. Kobe B, Deisenhofer J. A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature. 1995;374(6518):183–6. doi:10.1038/374183a0.
4. Kobe B, Deisenhofer J. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature. 1993;366(6457):751–6. doi:10.1038/366751a0.
5. Shapiro R. Cytoplasmic ribonuclease inhibitor. Methods Enzymol. 2001;341:611–28 (pii: S0076-6879(01)41180-3).
6. Futami J, Tsushima Y, Murato Y, Tada H, Sasaki J, Seno M, et al. Tissue-specific expression of pancreatic-type RNases and RNase inhibitor in humans. DNA Cell Biol. 1997;16(4):413–9.
7. Nadano D, Yasuda T, Takeshita H, Uchide K, Kishi K. Purification and characterization of human brain ribonuclease inhibitor. Arch Biochem Biophys. 1994;312(2):421–8. doi:10.1006/abbi.1994.1328.
8. Yao X, Li D, Xiong DM, Li L, Jiang R, Chen JX. A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells. Cell Tissue Res. 2013;353(3):409–23. doi:10.1007/s00441-013-1638-2.
9. Pan X, Xiong D, Yao X, Xin Y, Zhang L, Chen J. Up-regulating ribonuclease inhibitor inhibited epithelial-to-mesenchymal transition and metastasis in murine melanoma cells. Int J Biochem Cell Biol. 2012;44(6):998–1008. doi:10.1016/j.biocel.2012.03.008.
10. Chen JX, Gao Y, Liu JW, Tian YX, Zhao J, Cui XY. Antitumor effects of human ribonuclease inhibitor gene transfected on B16 melanoma cells. Int J Biochem Cell Biol. 2005;37(6):1219–31. doi:10.1016/j.biocel.2004.11.020.
11. Tian YX, Wang DM, Cui XY. Analysis of gene expression of ribonuclease inhibitor in human breast cancer tissue. Ai Zheng. 2004;23(3):269–72 (pii: 10000467X2004030269).
12. Fan J, Wang S, Yu S, He J, Zheng W, Zhang J. N-acetylglucosaminyltransferase IVa regulates metastatic potential of mouse hepatocarcinoma cells through glycosylation of CD147. Glycoconj J. 2012;29(5–6):323–34. doi:10.1007/s10719-012-9414-1.
13. Chen JS, Wang Q, Fu XH, Huang XH, Chen XL, Cao LQ, et al. Involvement of PI3 K/PTEN/AkT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: association with MMP-9. Hepatol Res. 2009;39(2):177–86. doi:10.1111/j.1872-034X.2008.00449.x.
14. Lee FS, Vallee BL. Structure and action of mammalian ribonuclease (angiogenin) inhibitor. Prog Nucleic Acid Res Mol Biol. 1993;44:1–30.
15. Kobe B, Kajava AV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol. 2001;11(6):725–32 (pii: S0959-440X(01)00266-4).
16. Xu ZP, Tsuji T, Riordan JF, Hu GF. The nuclear function of angiogenin in endothelial cells is related to rRNA production. Biochem Biophys Res Commun. 2002;294(2):287–92. doi:10.1016/S0006-291X(02)00479-5S0006-291X(02)00479-5.
17. Moroianu J, Riordan JF. Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc Natl Acad Sci U S A. 1994;91(5):1677–81.
18. Dickson KA, Haigis MC, Raines RT. Ribonuclease inhibitor: structure and function. Prog Nucleic Acid Res Mol Biol. 2005;80:349–74. doi:10.1016/S0079-6603(05)80009-1.
19. Dickson KA, Kang DK, Kwon YS, Kim JC, Leland PA, Kim BM, et al. Ribonuclease inhibitor regulates neovascularization by human angiogenin. Biochemistry. 2009;48(18):3804–6. doi:10.1021/bi9005094.
20. Fu P, Chen J, Tian Y, Watkins T, Cui X, Zhao B. Anti-tumor effect of hematopoietic cells carrying the gene of ribonuclease inhibitor. Cancer Gene Ther. 2005;12(3):268–75. doi:10.1038/sj.cgt.7700742.
21. Zhou JH, Tang XY, Zhao R, Wang H, Xia J. Effects of ribonuclease inhibitor on apoptosis and invasion of human breast cancer MDA-MB-231 cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012;28(3):260–4.
22. Pizzo E, Sarcinelli C, Sheng J, Fusco S, Formiggini F, Netti P, et al. Ribonuclease/angiogenin inhibitor 1 regulates stress-induced subcellular localization of angiogenin to control growth and survival. J Cell Sci. 2013;126(Pt 18):4308–19. doi:10.1242/jcs.134551.
23. Chen J, Ou-Yang X, Gao J, Zhu J, He X, Rong J. Knockdown of ribonuclease inhibitor expression with siRNA in non-invasive bladder cancer cell line BIU-87 promotes growth and metastasis potentials. Mol Cell Biochem. 2011;349(1–2):83–95. doi:10.1007/s11010-010-0663-7.
24. Wey JS, Fan F, Gray MJ, Bauer TW, McCarty MF, Somcio R, et al. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer. 2005;104(2):427–38. doi:10.1002/cncr.21145.
25. Xiao N, Qi XY, Tang LN, Tan LL, Chen YQ, Zhao HM. VEGF promotes cardiac stem cells differentiation into vascular endothelial cells via the PI3 K/Akt signaling pathway. Artif Cells Nanomed Biotechnol. 2013. doi:10.3109/21691401.2013.837473.
26. Xu J, Jia L, Ma H, Li Y, Ma Z, Zhao Y. Axl gene knockdown inhibits the metastasis properties of hepatocellular carcinoma via PI3 K/Akt-PAK1 signal pathway. Tumour Biol. 2013;35(4):3809–17. doi:10.1007/s13277-013-1521-5.
27. Sussman M. “AKT”ing lessons for stem cells: regulation of cardiac myocyte and progenitor cell proliferation. Trends Cardiovasc Med. 2007;17(7):235–40. doi:10.1016/j.tcm.2007.08.003.
28. Chetty C, Lakka SS, Bhoopathi P, Rao JS. MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3 K/AKT signaling in A549 lung cancer cells. Int J Cancer. 2010;127(5):1081–95. doi:10.1002/ijc.25134.
29. Achiwa Y, Hasegawa K, Udagawa Y. Regulation of the phosphatidylinositol 3-kinase-Akt and the mitogen-activated protein kinase pathways by ursolic acid in human endometrial cancer cells. Biosci Biotechnol Biochem. 2007;71(1):31–7 (pii: JSTJSTAGE/bbb/60288).
30. Molinari F, Frattini M. Functions and regulation of the PTEN gene in colorectal cancer. Front Oncol. 2014;3:326. doi:10.3389/fonc.2013.00326.